Approximately 90 percent of alarms in various critical care settings are either false or clinically irrelevant. An AACN Practice Alert outlines evidence-based protocols and clinical strategies that healthcare organizations can implement as they seek ways to reduce false or nonactionable alarms and improve the effective use of these monitoring aids.

In a new paper, published in the May 23 online issue of Science Translational Medicine, researchers at University of California San Diego School of Medicine report that adult rat myelin actually stimulated axonal outgrowth in rat neural precursor cells (NPCs) and human induced pluripotent (iPSC)-derived neural stem cells (NSCs).

Embargo expired:

Dr. Andrew Wall, dean of the School of Education at the University of Redlands, was named an Impact Academy fellow, joining a cohort of leaders chosen for their commitment to improving educator preparation. Wall is one of 13 fellows in the academy’s third cohort since its launch in summer 2016.

UCLA researchers lay out the probabilities that a person will develop Alzheimer’s disease dementia based on age, gender and the results of biomarker tests, which can detect the presence of certain protein fragments in brain and spinal fluid or for brain cell changes linked with the disease.

This is the first example of a novel mode of neurotransmitter-based communication and challenges current dogma about mechanisms of signaling in the brain. The findings uncover new pathways for developing therapies for disorders like epilepsy, anxiety and chronic pain.